← FDA Drug Approvals (Drugs@FDA)

AEMCOLO

NDA · New Drug Application · Sponsor: COSMO TECHNOLOGIES · Approved 2018-11-16

Drug application

FDA Application #

NDA210910

Application type

New Drug Application

Brand name

AEMCOLO

Generic name

Rifamycin Sodium

Active ingredients

RIFAMYCIN SODIUM

Dosage form

TABLET, DELAYED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

COSMO TECHNOLOGIES

First approval

2018-11-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown